BSE Sensex retreats from record high, drops 240 pts, Ranbaxy shares plunge 20 pct

Comments 0
While BSE Sensex fell over direction Raghuram Rajan's RBI rate meet will go, Ranbaxy Laboratories shares plunged after US FDA banned more of its products. While BSE Sensex fell over direction Raghuram Rajan's RBI rate meet will go, Ranbaxy Laboratories shares plunged after US FDA banned more of its products.
SummaryBSE Sensex retreats as rate sensitive stocks decline - Ranbaxy shares drop off cliff.

governor issued a strong warning on inflation.

The benchmark BSE index provisionally closed 1.09 per cent lower at 21,141.06, while the broader NSE Nifty closed 1.21 percent lower at 6,266.75.

Ranbaxy Laboratories Ltd, majority owned by Japan's Daiichi Sankyo Co Ltd, plunged 19.54 per cent to Rs 335.65 at the close on the BSE after the U.S. Food and Drug Administration banned more products from the Indian drugmaker.

Single Page Format
Ads by Google
Reader´s Comments
| Post a Comment
Please Wait while comments are loading...